This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Genentech, Inc., The University of Texas System. Active years: 1996-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 3,299 
2 out of 5,638 
Years Active: 1996-2005
Title: The Innovations of James C. Marsters
Introduction
James C. Marsters is a notable inventor based in Oakland, CA, with a significant contribution to the field of biochemistry. He holds a total of four patents, showcasing his innovative approach to developing compounds that have potential therapeutic applications.
Latest Patents
Among his latest inventions are LFA-1 antagonist compounds. These novel compounds are characterized by a specific formula wherein Cy, X, Y, L, and R are defined. The compounds are designed to bind to CD11/CD18 adhesion receptors, such as Lymphocyte Function-associated Antigen-1 (LFA-1). This binding mechanism makes them useful for treating disorders mediated by LFA-1, including inflammation and autoimmune diseases.
Career Highlights
James has had a distinguished career, working with prominent organizations such as Genentech, Inc. and the University of Texas System. His work in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Throughout his career, James has collaborated with esteemed colleagues, including David A. Oare and Mark E. Reynolds. These partnerships have further enriched his research and innovation efforts.
Conclusion
James C. Marsters exemplifies the spirit of innovation in the field of biochemistry through his patents and collaborations. His work continues to have a lasting impact on the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile